Retinal ganglion cell death in glaucoma: The how, the why, and the maybe

Journal of Glaucoma

Volumn 5, Issue 5, 1996, Pages 345-356

  Nickells, Robert W ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Apoptosis; Glutamate toxicity; Neurotrophins; Retinal ganglion cells

Indexed keywords

GLUTAMIC ACID; NEUROTROPHIC FACTOR; NEUROTROPHIN;

APOPTOSIS; ARTICLE; CELL DEATH; COMPLICATION; ETIOLOGY; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; PREVENTION; PRIORITY JOURNAL; RETINA GANGLION CELL; RETROGRADE NERVE FIBER TRANSPORT;

ANIMALS; APOPTOSIS; CELL DEATH; DISEASE MODELS, ANIMAL; GLAUCOMA; HUMANS; RETINAL GANGLION CELLS;

EID: 0029908754     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Quigley HA. The number of persons with glaucoma worldwide. Br J Ophthalmol 1996;80:389-93.
2. Jampel H, Nickells RW, Zack DJ. Genetics of glaucoma. In: Conner JM, Rimoin DL, Pyeritz RE, eds. Principles and practice of medical genetics. London: Churchill Livingston (in press).
3. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995;146:3-15.
4. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
5. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
6. Garcia-Valenzuela E, Gorczyca W, Darzynkiewicz Z, Sharma SC. Apoptosis in adult retinal ganglion cells after axotomy. J Neurobiol 1994;25:431-8.
7. Buja LM, Eigenbrodt ML, Eigenbrodt EH. Apoptosis and necrosis. Basic types and mechanisms of cell death. Arch Pathol Lab Med 1993;117:1208-14.
8. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995;146:1220-34.
9. Ankarcrona M, Dypbukt JM, Bonfoco E, et al. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995;15: 961-73.
10. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and macromolecular synthesis. J Pathol 1984; 142:67-77.
11. Quigley HA, Addicks EM. Chronic experimental glaucoma in primates. I. Production of elevated intraocular pressure by anterior injection of autologous ghost red blood cells. Invest Ophthalmol Vis Sci 1980;19:126-36.
12. Varma R, Quigley HA, Pease ME. Changes in optic disk characteristics and the number of nerve fibers in experimental glaucoma. Am J Ophthalmol 1992;114:554-9.
13. Gaasterland D, Tanishima T, Kuwabara T. Axoplasmic flow during chronic experimental glaucoma I. Light and electron microscopic studies of the monkey optic nervehead during development of glaucomatous cupping. Invest Ophthalmol Vis Sci 1978:17:838-46.
14. Quigley HA, Addicks EM. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest Ophthalmol Vis Sci 1980;19:137-52.
15. Glovinsky Y, Quigley HA, Dunkelberger GR. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthatmol Vis Sci 1991;32:484-91.
16. Quigley HA, Addicks EM. Quantitative studies of retinal nerve fiber layer defects. Arch Ophthalmol 1982;100:807-14.
17. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995;36:774-86.
18. Sanchez RM, Dunkelberger GR, Quigley HA. The number and diameter distribution of axons in the monkey optic nerve. Invest Ophthalmol Vis Sci 1986;27:1342-50.
19. Büchi ER. Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: an electron microscopic study. I. Ganglion cell layer and inner nuclear layer. Exp Eye Res 1992;55:605-13.
20. Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 1995;61:33-44.
21. Berkelaar M, Clarke DB, Wang Y-C, Aguayo AJ. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci 1994;14:4368-74.
22. Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci 1991;14:453-501.
23. Levin LA, Louhab A. Apoptosis of retinal ganglion cells in anterior ischemic optic neuropathy. Arch Ophthalmol 1996;114:488-91.
24. Tsujimoto Y, Gorham J, Crossman J, Jaffe E, Croce CM. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985;229:1390-3.
25. Seto M, Jaeger U, Graninger W, Bennett S, Goldman P, Korsmeyer SJ. Alternative promoters and exons, somatic mutation and deregulation of the bcl-2-Ig fusion gene in lymphoma. EMBO J 1988;7:123-31.
26. Boise LH, González-García M, Postema CE, et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608.
27. Oltvai Z, Milliman C, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
28. Yin X-M, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994;369:321-3.
29. Allsopp TE, Wyatt S, Paterson HF, Davies AM. The protooncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 1993;73:295-307.
30. Deng G, Podack ER. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc Natl Acad Sci USA 1993;90:2189-93.
31. Mah SP, Zhong LT, Liu Y, Roghani A, Edwards RH, Bredesen DE. The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J Neurochem 1993;60:1183-6.
32. Freeman RS, Estus S, Johnson JEM. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron 1994;12:343-55.
33. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 352:345-7.
34. Ryan JJ, Prochownik E, Gottlieb CA, et al. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA 1994;91:5878-82.
35. Zambetti GP, Levine AJ. A comparison of the biological activities of wild-type and mutant p53. FASEB J 1993;7:855-65.
36. Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 1994;54:3131-5.
37. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80:293-9.
38. Martinou J-C, Dubois-Dauphin M, Staple JK, et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death an experimental ischemia. Neuron 1994;13:1017-30.
39. Bonfanti L, Chierzi S, Cenni MC, et al. Survival of retinal ganglion cells over-expressing Bcl-2 protein in neonatal transgenic mice following optic nerve section. Soc Neurosci Abstr 1995;21:1556.
40. Levin LA, Geszvain K, Nickells RW. Altered expression of BH1/BH2 family genes following retinal ganglion cell axotomy. Soc Neurosci Abstr 1995;21:2018.
41. Schlessinger J, Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron 1992;9:383-91.
42. Johnson JE, Barde Y-A, Schwab M, Thoenen H. Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. J Neurosci 1986;6:3031-8.
43. Cohen-Cory S, Fraser SE. BDNF in the development of the visual system of Xenopus. Neuron 1994;12:747-61.
44. Rodriguez-Tébar A, Jeffrey PL, Thoenen H, Barde YA. The survival of chick retinal ganglion cells in response to brain-derived neurotrophic factor depends on their embryonic age. Dev Biol 1989;136:296-303.
45. Mansour-Robaey S, Clarke DB, Wang Y-C, Bray GM, Aguayo AJ. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci USA 1994;91:1632-6.
46. Anderson DR, Hendrickson A. Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest Ophthalmol 1974;13:771-83.
47. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol 1981;99:635-49.
48. Radius RL, Anderson DR. Rapid axonal transport in primate optic nerve. Arch Ophthalmol 1981;99:650-4.
49. Dandona L, Hendrickson A, Quigley HA. Selective effects of experimental glaucoma on axonal transport by retinal ganglion cells to the dorsal lateral geniculate nucleus. Invest Ophthalmol Vis Sci 1991;32:484-91.
50. Hayreh SS. Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, and oedema of the optic disc. Br J Ophthalmol 1969;53:721-48.
51. Hayreh SS, Revie IH, Edwards J. Vasogenic origin of visual field defects and optic nerve changes in glaucoma. Br J Ophthalmol 1970;54:721-48.
52. Quigley HA, Addicks EM. Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch Ophthalmol 1981;99:137-43.
53. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. The role of nocturnal hypotension in ocular and optic nerve ischemic disorders. Invest Ophthalmol Vis Sci 1993;34:994.
54. Lipton S, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994;330:613-22.
55. Schmidt HHHW, Walter U. NO at work. Cell 1994;78:919-25.
56. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 1991;88: 6368-71.
57. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 1993;13:2651-61.
58. Stamler J. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994;78:931-6.
59. Zhang J, Dawson VL, Dawson TM, Snyder SH. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 1994;263:687-9.
60. Messemer UK, Ankarcrona M, Nicotera P, Brune B. p53 expression in nitric oxide-induced apoptosis. FEBS Lett 1994;355:23-6.
61. Fehsel K, Kroncke KD, Meyer KL, Huber H, Wahn V, Kolb-Bachofen V. Nitric oxide induces apoptosis in mouse thymocytes. J Immunol 1995;155:2858-65.
62. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 1996; 114:299-305.
63. Dreyer EB, Pan ZH, Storm S, Lipton SA. Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death. Neuroreport 1994;5:629-31.
64. Quigley HA, Dunkelberger GR, Green WR. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology 1988;95:357-63.
65. Glovinsky Y, Quigley HA, Pease ME. Foveal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci 1993;34:395-400.
66. Dessi F, Charriaut-Marlangue C, Khrestchatisky M, Ben-Ari Y. Glutamate-induced neuronal death is not programmed cell death in cerebellar culture. J Neurochem 1993;60: 1953-5.
67. Linnik MD, Zobrist RH, Hatfield MD. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 1993;24:2002-8.
68. MacManus JP, Hill IE, Huang ZG, Rasquinha I, Xue D, Buchan AM. DNA damage consistent with apoptosis in transient focal ischaemic neocortex. Neuroreport 1994;5:493-6.
69. Maiese K, Boniece I, DeMeo D, Wagner J. Peptide growth factors protect against ischemia in culture by preventing nitric oxide toxicity. J Neurosci 1993;13:3034-40.
70. Bonfoco E, Kranic D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate of nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995;92:7162-6.
71. Garcia I, Martinou I, Tsujimoto Y, Martinou J-C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 1992;258:302-4.
72. Zhong L, Kane DJ, Bredesen DE. BCL-2 blocks glutamate toxicity in neural cell lines. Mol Brain Res 1993;19:353-5.
73. Zack DJ. Ocular gene therapy. From fantasy to foreseeable reality. Arch Ophthalmol 1993;111:1477-9.
74. Pepose JS, Leib DA. Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues. Invest Ophthalmol Vis Sci 1994;35:2662-6.
75. Bennett J, Wilson J, Sun D, Forbes B, Maguire A. Adeno-virus vector-mediated in vivo gene transfer into adult murine retina. Invest Ophthalmol Vis Sci 1994;35:2535-42.
76. Li T, Adamian M, Roof DJ, et al. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest Ophthalmol Vis Sci 1994;35:2543-9.
77. Sievers J, Hausmann B, Unsicker K, Berry M. Fibroblast growth factors promote the survival of adult rat retinal ganglion cells after transection of the optic nerve. Neurosci Lett 1987;76:157-62.
78. Mey J, Thanos S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res 1993;602:304-17.
79. Barinaga M. Neurotrophic factors enter the clinic. Science 1994;264:772-4.
80. Chen H-S, Pellegrini JW, Aggarwal SK, et al. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 1992;12:4427-36.
81. Batistatou A, Greene LA. Aurintricarboxylic acid rescues PC12 cells and sympathetic, neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity. J Cell Biol 1991;115: 461-71.
82. Levin LA, Clarke JA. Effect of the 21-aminosteroid U74006F on rat retina ganglion cell death. Invest Ophthalmol Vis Sci 1995;36:S674.
83. Greenland LJS, Deckwerth TL, Johnson JEM. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 1995; 14:303-15.